Highly selective whole-cell 25-hydroxyvitamin D3 synthesis using molybdenum-dependent C25-steroid dehydrogenase and cyclodextrin recycling

Dennis Kosian,Max Willistein,Ralf Weßbecher,Constantin Eggers,Oliver May,Matthias Boll
DOI: https://doi.org/10.1186/s12934-024-02303-6
IF: 6.352
2024-01-23
Microbial Cell Factories
Abstract:The global prevalence of vitamin D (VitD) deficiency associated with numerous acute and chronic diseases has led to strategies to improve the VitD status through dietary intake of VitD-fortified foods and VitD supplementation. In this context, the circulating form of VitD 3 (cholecalciferol) in the human body, 25-hydroxy-VitD 3 (calcifediol, 25OHVitD 3 ), has a much higher efficacy in improving the VitD status, which has motivated researchers to develop methods for its effective and sustainable synthesis. Conventional monooxygenase-/peroxygenase-based biocatalytic platforms for the conversion of VitD 3 to value-added 25OHVitD 3 are generally limited by a low selectivity and yield, costly reliance on cyclodextrins and electron donor systems, or by the use of toxic co-substrates.
biotechnology & applied microbiology
What problem does this paper attempt to address?